Hormones, Cognition and Dementia: State of the Art and Emergent Therapeutic Strategies

  • ISBN13:


  • ISBN10:


  • Edition: 1st
  • Format: Hardcover
  • Copyright: 2009-10-30
  • Publisher: Cambridge University Press

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $124.00 Save up to $31.00
  • Buy Used
    Add to Cart Free Shipping


Supplemental Materials

What is included with this book?


A decade ago, oestrogen-containing hormone therapy was viewed as a promising strategy for the prevention and treatment of dementia and age-related cognitive decline. However, treatment trials in women with Alzheimer's disease showed that oestrogens did not reverse cognitive impairment, and clinical trials in healthy older women indicated that oestrogens did not prevent cognitive decline. The Women's Health Initiative Memory Study trial even suggested an increased risk of dementia with treatment late in life. What happened? How are we to understand these findings? What are the implications for middle-aged and older women? What about testosterone, and what about men? And where do we go from here? This book brings together world-renowned experts in basic and clinical research on sex steroids, aging, and cognition to integrate existing findings with emerging new data, and offer challenging hypotheses on these key issues.

Author Biography

Eef Hogervorst is Professor Department of Human Sciences, Loughborough University Loughborough, UK; Visiting Senior Research Fellow, Department of Public Health and Primary Care, University of Cambridge, UK; Visiting Professor, Department of Epidemiology and Public Health, University of Respati, Jakarta, Indonesia. Victor W. Henderson is Professor of Health Research Policy (Epidemiology) and of Neurology Neurological Sciences, Stanford University, CA, USA. Robert B. Gibbs is Professor of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, USA. Roberta Diaz Brinton is Professor of Pharmacology and Pharmaceutical Sciences, Neuroscience and Biomedical Engineering, University of Southern California, Los Angeles, CA, USA.

Table of Contents

List of contributorsp. vii
Prefacep. xi
Estrogens and cognition: perspectives and opportunities in the wake of the Women's Health Initiative Memory Study
Women's Health Initiative Memory Study (WHIMS) program: emerging findingsp. 1
Identifying risk factors for cognitive change in the Women's Health Initiative: a neural networks approachp. 11
Estrogen therapy - relationship to longevity and prevalent dementia in the oldest-old: the Leisure World Cohort Study and the 90+ Studyp. 25
The critical window hypothesis: hormone exposures and cognitive outcomes after menopausep. 32
Animal studies that support estrogen effects on cognitive performance and the cholinergic basis of the critical period hypothesisp. 45
The healthy cell bias of estrogen action through regulating glucose metabolism and mitochondrial function: implications for prevention of Alzheimer's diseasep. 55
Varieties of estrogenic therapy
Alternative estrogenic treatment regimens and the Kronos Early Estrogen Prevention Study - Cognitive and Affective substudy (KEEPS-CA)p. 65
The use of transdermal 17ß-estradiol in the treatment of Alzheimer's diseasep. 80
Alternative modes of treatment: pulsatile estradiol treatmentp. 87
In search of estrogen alternatives for the brainp. 93
Potential modulators and modifiers of estrogenic effects
Progesterone regulation of neuroprotective estrogen actionsp. 101
Clinical data of estrogen's effects in the central nervous system: estrogen and moodp. 110
Different forms of soy processing may determine the positive or negative impact on cognitive function of Indonesian elderlyp. 121
Hypothalamus-pituitary-adrenal axis activity in aging women: its impact on the brain and the potential influence of estradiolp. 133
Possible genetic factors related to hormone treatment effects
Possible genetic polymorphisms related to sex steroid metabolism and dementia in womenp. 143
Genetics related to sex steroids: implications for Alzheimer's diseasep. 153
Apolipoprotein E, hormone therapy, and neuroprotectionp. 162
Testosterone, gonadotropins, and genetic polymorphisms in men with Alzheimer's diseasep. 171
Testosterone, estradiol and men, and sex hormone binding globulin
Androgens and cognitive functioning in womenp. 179
The role of estradiol in testosterone treatmentp. 187
Endogenous testosterone levels and cognitive aging in menp. 197
Clinical trials and neuroimaging studies of testosterone in men: insights into effects on verbal memoryp. 208
Testosterone therapy and Alzheimer's disease: potential for treatment and prevention in womenp. 220
Endogenous estradiol and dementia in elderly men: the roles of vascular risk, sex hormone binding globulin, and aromatase activityp. 228
Testosterone regulates Alzheimer's disease pathogenesisp. 242
Gonadotropin effects
Involvement of gonadotropins in cognitive function: implications for Alzheimer's diseasep. 251
The role of gonadotropins and testosterone in the regulation of beta-amyloid metabolismp. 259
Epiloguep. 269
Concluding remarksp. 271
Indexp. 275
Table of Contents provided by Ingram. All Rights Reserved.

Rewards Program

Write a Review